Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase III MUSETTE trial comparing a high dose of Ocrevus® (ocrelizumab) intravenous (IV) infusion to the currently approved Ocrevus IV 600 mg dose in people with …

Deals: Novo Nordisk is licensing a drug called LX9851 from Lexicon Pharmaceuticals for up to $75 million in upfront and near-term payments, if the latter meets certain development goals. Lexicon is eligible to earn up to $1 billion from later R&D, …

… authorize the use of a multiple sclerosis drug that failed clinical trials … VACCINE INJURIES. Finally! For years, vaccine-injured Americans have been gaslit …

Trinity researcher’s findings highlight potential causal link between MS and Epstein Barr virus, opening up the possibility of new improved treatments A neurologist has been honoured for his recent work in multiple sclerosis (MS) research, including a …

Early in this week’s episode, Dr. Whittaker finally gets a moment free of blood, piss, and rats. He enters the peds morgue to retrieve a blanket and runs into Dr. Robby amid his breakdown over the death of Jake’s girlfriend, Leah. Whittaker tells a …

Analyzing the Theranos Appeals Matthew Yelovich, partner at Cleary Gottlieb, discusses the appeals of Elizabeth Holmes and Ramesh "Sunny" Balwani and the Ninth Circuit's recent affirmation of their convictions. Current CAR-T Therapy Trends in …

Mary-Frances O’Connor: I think that people are really hungry to understand scientifically what’s happening with people, so they want to understand what are people going through, but also why? Paul Rand: As it turns out, grief can physically impact our body …

A protest at the U.S. Capitol for equal rights in public accommodations for people with disabilities in 1972. Photo: Bettmann Archive/Getty Images This article was featured in One Great Story, New York’s reading recommendation newsletter. Sign up here …

Description of the zoster vaccine rollout in Wales The live-attenuated zoster vaccine (Zostavax) was made available to eligible individuals in Wales through a staggered rollout system starting on 1 September 2013. Under this system, individuals aged 71 …

New research findings provide solid evidence that annual COVID-19 vaccine booster doses continue to be advisable for certain immunocompromised people, researchers at McGill University say. The researchers looked at how often people with immune-mediated …